Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2010
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101127A1 Indole compound
09/10/2010WO2010100606A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010WO2010100189A1 3-arylquinazolin-4-one compounds for combating invertebrate pests
09/10/2010WO2010100070A1 Inhibitors of bruton's tyrosine kinase
09/10/2010WO2010056022A3 Melanocortin receptor agonists
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010CA2754570A1 Neurotrophin mimetics and uses thereof
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/10/2010CA2753552A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010CA2753341A1 Inhibitors of bruton's tyrosine kinase
09/10/2010CA2751836A1 3-arylquinazolin-4-one compounds for combating invertebrate pests
09/10/2010CA2751534A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
09/10/2010CA2750862A1 Fungicidal pyrazoles
09/09/2010US20100227969 Aziridine crosslinking agents for acrylic adhesives
09/09/2010US20100227906 C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers
09/09/2010US20100227872 Pyrazine derivatives
09/09/2010US20100227869 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100227846 Substituted pyrazole derivative
09/09/2010US20100227186 Compounds and their use for producing leather and as dispersants
09/09/2010US20100227108 Bridged cyanine compound and optical recording material using the same
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/09/2010US20100226918 Pyrrole derivatives as p2y12 antagonists
09/09/2010US20100226883 Linked diimidazole derivatives
09/08/2010EP2226322A1 Imidazole carbonyl compound
09/08/2010EP2226319A1 Process for the preparation of 2-(2-Amino-pyrimidin-4-yl)-1H-indol-5-carbonic acid derivatives
09/08/2010EP2226316A1 Copper-catalysed ligation of azides and acetylenes
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2225227A2 Compounds
09/08/2010EP2225226A1 Compounds and method for treatment of cancer
09/08/2010EP2225225A2 Angiotensin ii receptor antagonists
09/08/2010EP2225224A2 Novel hemioxalate salt of eletriptan
09/08/2010EP2225211A1 Herbicidal pyridazinone derivatives
09/08/2010EP2225210A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
09/08/2010EP2224928A1 Novel seh inhibitors and their use
09/08/2010EP1919878B1 Pyridazinone derivatives as thyroid hormone receptor agonists
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010EP0882717B1 Nitrogenous heterocyclic compounds
09/08/2010CN1993354B Preparation of hydrochloride salts of tetrazole derivative
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
09/08/2010CN101827828A 1, 2, 4 -triazole derivatives as serotonergic modulators
09/08/2010CN101824029A Tyrosine kinase irreversible inhibitor and medicine composition and application thereof
09/08/2010CN101824002A Water soluble triazole compound and synthesis method thereof
09/08/2010CN101260102B Antineoplastic activity marine indole alkaloids substances, and preparation method and application thereof
09/08/2010CN101099740B Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
09/08/2010CN101080403B Novel hydantoin derivatives as metalloproteinase inhibitors
09/08/2010CN101044123B Pyrimidine derivative fused with nonaromatic ring
09/07/2010US7790893 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes
09/07/2010US7790751 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
09/07/2010US7790745 modulators of nuclear receptors, including liver X receptor (LXR), such as 2-tert-butyl 1-methyl 6-(3- methoxybenzyloxy)-3,4- dihydroisoquinoline-1,2(1H)- dicarboxylate, useful in the treatment of arteriosclerosis, atherosclerosis, hypercholesterolemia, hyperlipemia, hypertriglyceridemia and diabetes
09/07/2010US7790743 Modulators of cellular adhesion
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790734 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; anticancer agents; skin disorders
09/07/2010US7790725 Thiazolidine derivatives and medicinal use thereof
09/07/2010US7790724 c-fms kinase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790710 Imidazopyridine derivatives useful as iNOS inhibitors
09/07/2010US7790707 S1P receptor modulating compounds and use thereof
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010CA2521081C Pyrimidin-4-one derivatives and their use as p38 kinase modulators
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/02/2010WO2010099379A1 Jak kinase modulating quinazoline derivatives and methods of use thereof
09/02/2010WO2010099039A1 Indole derivatives as crth2 receptor antagonists
09/02/2010WO2010098119A1 Complex compound and organic electroluminescent device containing the complex compound
09/02/2010WO2010098098A1 Pyrromethene-boron complex compounds and organic electro- luminescent elements using same
09/02/2010WO2010097703A1 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097433A1 Quinone compounds as dopants in organic electronics
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2010053861A3 Biologically active amides
09/02/2010WO2010044885A3 Soluble mtor complexes and modulators thereof
09/02/2010WO2010019417A3 Chymase inhibitors
09/02/2010US20100222597 Process for the preparation of losartan
09/02/2010US20100222588 Method for Manufacture of 2-Oxoimidazolidines
09/02/2010US20100222587 Compositions and methods for the intraocular transport of therapeutic agents
09/02/2010US20100222581 Novel isophthalates as beta-secretase inhibitors
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222402 Method of manufacturing 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1yl]methyl]biphenyl-2-carboxylic acid (telmisartan)
09/02/2010US20100222372 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222359 Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222357 Indol-3-y-carbonyl-piperidin and piperazin-derivatives
09/02/2010US20100222353 Aminophthalazine derivative compounds
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222342 Pyrrolopyrazole, potent kinase inhibitors
09/02/2010US20100222341 Piperidine and piperazine derivatives
09/02/2010US20100222331 New compounds
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100222322 Non-Nucleoside Reverse Transcriptase Inhibitors
09/02/2010US20100222320 Triazole derivatives for treating alzheimer's disease and related conditions
09/02/2010US20100222318 Compounds useful as inhibitors of atr kinase
09/02/2010US20100222302 Novel Antibacterial Compounds
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 626